Kang-Ling Wang

1.9k total citations
35 papers, 1.1k citations indexed

About

Kang-Ling Wang is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Internal Medicine. According to data from OpenAlex, Kang-Ling Wang has authored 35 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Cardiology and Cardiovascular Medicine, 14 papers in Surgery and 9 papers in Internal Medicine. Recurrent topics in Kang-Ling Wang's work include Atrial Fibrillation Management and Outcomes (17 papers), Cardiac Arrhythmias and Treatments (10 papers) and Venous Thromboembolism Diagnosis and Management (9 papers). Kang-Ling Wang is often cited by papers focused on Atrial Fibrillation Management and Outcomes (17 papers), Cardiac Arrhythmias and Treatments (10 papers) and Venous Thromboembolism Diagnosis and Management (9 papers). Kang-Ling Wang collaborates with scholars based in Taiwan, United States and United Kingdom. Kang-Ling Wang's co-authors include Gregory Y.H. Lip, Chern‐En Chiang, Chern‐En Chiang, Shing‐Jong Lin, Ta‐Chuan Tuan, Yenn‐Jiang Lin, Shinya Goto, Tze‐Fan Chao, Yu‐Feng Hu and Tzeng‐Ji Chen and has published in prestigious journals such as Journal of the American College of Cardiology, Stroke and European Heart Journal.

In The Last Decade

Kang-Ling Wang

35 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kang-Ling Wang Taiwan 15 886 401 214 124 91 35 1.1k
Thure Filskov Overvad Denmark 18 986 1.1× 399 1.0× 225 1.1× 106 0.9× 143 1.6× 51 1.2k
Ying X. Gue United Kingdom 13 611 0.7× 163 0.4× 145 0.7× 122 1.0× 77 0.8× 65 860
Henrik Renlund Sweden 17 878 1.0× 290 0.7× 103 0.5× 346 2.8× 130 1.4× 51 1.0k
Hans Lanz United States 17 1.2k 1.3× 672 1.7× 184 0.9× 114 0.9× 58 0.6× 32 1.3k
Helen Varker United States 11 736 0.8× 209 0.5× 77 0.4× 94 0.8× 87 1.0× 36 1.0k
Lynn B. Oertel United States 8 980 1.1× 312 0.8× 95 0.4× 130 1.0× 125 1.4× 11 1.1k
Gregory Lip United Kingdom 16 508 0.6× 111 0.3× 97 0.5× 75 0.6× 33 0.4× 39 632
Bcps United States 5 724 0.8× 508 1.3× 172 0.8× 136 1.1× 24 0.3× 48 985
Jindřich Špinar Czechia 12 616 0.7× 94 0.2× 86 0.4× 141 1.1× 121 1.3× 127 834
Jérémie Abtan France 13 524 0.6× 140 0.3× 114 0.5× 294 2.4× 41 0.5× 40 647

Countries citing papers authored by Kang-Ling Wang

Since Specialization
Citations

This map shows the geographic impact of Kang-Ling Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kang-Ling Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kang-Ling Wang more than expected).

Fields of papers citing papers by Kang-Ling Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kang-Ling Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kang-Ling Wang. The network helps show where Kang-Ling Wang may publish in the future.

Co-authorship network of co-authors of Kang-Ling Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Kang-Ling Wang. A scholar is included among the top collaborators of Kang-Ling Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kang-Ling Wang. Kang-Ling Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Daghem, Marwa, Philip D Adamson, Kang-Ling Wang, et al.. (2023). Temporal Changes in Coronary18F-Fluoride Plaque Uptake in Patients with Coronary Atherosclerosis. Journal of Nuclear Medicine. 64(9). 1478–1486. 7 indexed citations
2.
3.
Meah, Mohammed N., Evangelos Tzolos, Kang-Ling Wang, et al.. (2022). Plaque Burden and 1-Year Outcomes in Acute Chest Pain. JACC. Cardiovascular imaging. 15(11). 1916–1925. 22 indexed citations
4.
5.
Wang, Kang-Ling, Eng Soo Yap, Shinya Goto, et al.. (2018). The diagnosis and treatment of venous thromboembolism in Asian patients. Thrombosis Journal. 16(1). 4–4. 64 indexed citations
6.
Wang, Kang-Ling, Nick van Es, Chris Cameron, et al.. (2018). Extended treatment of venous thromboembolism: a systematic review and network meta-analysis. Heart. 105(7). 545–552. 24 indexed citations
7.
Wang, Kang-Ling, Robert P. Giugliano, Doreen Su‐Yin Tan, et al.. (2017). Drug Class, Renal Elimination, and Outcomes of Direct Oral Anticoagulants in Asian Patients: A Meta-Analysis. Journal of Stroke and Cerebrovascular Diseases. 27(4). 857–864. 2 indexed citations
8.
Wang, Kang-Ling, Doreen Su‐Yin Tan, Chun-Yi Lin, et al.. (2017). Once- or twice-daily non-vitamin K antagonist oral anticoagulants in Asian patients with atrial fibrillation: A meta-analysis of randomized controlled trials. Journal of the Formosan Medical Association. 116(8). 591–598. 6 indexed citations
9.
10.
Chiang, Chern‐En, Kang-Ling Wang, & Shing‐Jong Lin. (2015). Asian strategy for stroke prevention in atrial fibrillation. EP Europace. 17(suppl 2). ii31–ii39. 34 indexed citations
11.
Wang, Kang-Ling, Cheng‐Hsueh Wu, Chun‐Chin Chang, et al.. (2014). The Association between Low-Density Lipoprotein Cholesterol Goal Attainment, Physician and Patient Attitudes and Perceptions, and Healthcare Policy. Journal of Atherosclerosis and Thrombosis. 21(10). 1044–1054. 4 indexed citations
12.
Wang, Kang-Ling, Gregory Y.H. Lip, & Chern‐En Chiang. (2014). Stroke prevention in atrial fibrillation: An Asian perspective. Thrombosis and Haemostasis. 112(5). 789–797. 222 indexed citations
13.
Wang, Kang-Ling, Cheng‐Hsueh Wu, Chin‐Chou Huang, et al.. (2014). Complexity of atrial fibrillation patients and management in Chinese ethnicity in routine daily practice: Insights from the RealiseAF Taiwanese cohort. Journal of Cardiology. 64(3). 211–217. 12 indexed citations
14.
Lip, Gregory Y.H., Kang-Ling Wang, & Chern‐En Chiang. (2014). Non-vitamin K antagonist oral anticoagulants (NOACs) for stroke prevention in Asian patients with atrial fibrillation: Time for a reappraisal. International Journal of Cardiology. 180. 246–254. 135 indexed citations
15.
Chao, Tze‐Fan, Chia-Jen Liu, Kang-Ling Wang, et al.. (2014). Incidence and prediction of ischemic stroke among atrial fibrillation patients with end-stage renal disease requiring dialysis. Heart Rhythm. 11(10). 1752–1759. 65 indexed citations
16.
Chang, Chun‐Chin, Kang-Ling Wang, Cheng‐Hsueh Wu, et al.. (2013). Determinants of low-density lipoprotein cholesterol goal attainment: Insights from the CEPHEUS Pan-Asian Survey. Journal of the Chinese Medical Association. 77(2). 61–67. 9 indexed citations
17.
Chiang, Chern‐En & Kang-Ling Wang. (2012). STATIN, RISK OF DIABETES AND IMPACTS ON MORTALITY: INSIGHT FROM TAIWAN NATIONAL HEALTH INSURANCE DATABASE. Journal of the American College of Cardiology. 59(13). E1657–E1657. 2 indexed citations
18.
Chao, Tze‐Fan, Shih‐Hsien Sung, Kang-Ling Wang, et al.. (2011). Atrial Electromechanical Interval Can Identify Patients With Paroxysmal Atrial Fibrillation and is Associated With CHADS2 Score and Peak Velocity of Left Atrial Appendage. Journal of Cardiovascular Electrophysiology. 22(12). 1325–1330. 12 indexed citations
19.
Wang, Kang-Ling, et al.. (2006). Subfascial Hematoma Progressed to Arm Compartment Syndrome due to a Nontransposed Brachiobasilic Fistula. American Journal of Kidney Diseases. 48(6). 990–992. 5 indexed citations
20.
Wang, Kang-Ling, Liang‐Yu Lin, Po‐Min Chen, & Hong-Da Lin. (2005). Chronic Myeloid Leukemia After Treatment with 131I for Thyroid Carcinoma. Journal of the Chinese Medical Association. 68(5). 230–233. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thure Filskov Overvad Breakdown of academic impact, for papers by Ying X. Gue Breakdown of academic impact, for papers by Henrik Renlund Breakdown of academic impact, for papers by Hans Lanz Breakdown of academic impact, for papers by Helen Varker Breakdown of academic impact, for papers by Lynn B. Oertel Breakdown of academic impact, for papers by Gregory Lip Breakdown of academic impact, for papers by Bcps Breakdown of academic impact, for papers by Jindřich Špinar Breakdown of academic impact, for papers by Jérémie Abtan
Rankless by CCL
2026